Not yet recruitingObservationalLast updated Aug 14, 2026

Tornier Perform™ Reversed Monopost Study

Overview

ClinicalTrials.gov ID: NCT07764614
Lead Sponsor: Stryker Trauma and ExtremitiesINDUSTRY
Brief Summary: This study is a Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System.
Study Type: Observational

Conditions

Non-inflammatory Degenerative Joint DiseaseRhematoid ArthritisCorrection of Functional DeformityFracture of the Humeral HeadTraumatic ArthritisRevision of the Devices if Sufficient Bone Stock Remains

Status

Overall Status: Not yet recruiting
Start Date: Sep 28, 2026Estimated
Primary Completion Date: Dec 30, 2030Estimated
Completion Date: Aug 30, 2031Estimated

Study Record Dates

First Submitted: Aug 5, 2026
First Submitted that Met QC Criteria: Aug 12, 2026
First Posted: Aug 14, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 12, 2026
Last Update Posted: Aug 14, 2026Actual
Last Verified: Aug 2026

NCT05067543Recruiting

Perform Humeral System Study

NCT05773352Active, not recruiting

Perform® Humeral System - Fracture Study (PFX)

NCT05500066Enrolling by invitation

Tornier HRS (Humeral Reconstruction System) Study (REVIVE)

NCT02047955Terminated

Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients

NCT02204228Terminated

TITAN™ Reverse Shoulder System

NCT05351112Recruiting

PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder 2.0 Fracture System